X-73213817-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_021963.4(NAP1L2):c.676G>T(p.Ala226Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000174 in 1,208,310 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021963.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000181 AC: 2AN: 110369Hom.: 0 Cov.: 22 AF XY: 0.0000307 AC XY: 1AN XY: 32595
GnomAD3 exomes AF: 0.000104 AC: 19AN: 182699Hom.: 0 AF XY: 0.0000892 AC XY: 6AN XY: 67251
GnomAD4 exome AF: 0.0000173 AC: 19AN: 1097941Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 7AN XY: 363317
GnomAD4 genome AF: 0.0000181 AC: 2AN: 110369Hom.: 0 Cov.: 22 AF XY: 0.0000307 AC XY: 1AN XY: 32595
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.676G>T (p.A226S) alteration is located in exon 1 (coding exon 1) of the NAP1L2 gene. This alteration results from a G to T substitution at nucleotide position 676, causing the alanine (A) at amino acid position 226 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at